Kedalion Therapeutics Secures Series B Funding and Announces Signing of Option to Acquire Agreement

MENLO PARK, Calif.--(BUSINESS WIRE)--Kedalion Therapeutics has announced completion of its Series B financing led by Novartis and involving a combination of new and existing investors.

Click to view original post